TNBC stands for a promiscuous group of breast cancer, and TNBC is also characterized by a high proportion of CSCs as assessed by expression of the CSC marker CD44+/CD24− (ref. 17) or aldehyde dehydrogenase (ALDH)18. This evidence concerns the gene CD44 and breast carcinoma.